Argenta is a global contract research, development, and manufacturing organization (CRO/CDMO) focused exclusively on animal health. They provide comprehensive services from drug development to regulatory and clinical services to manufacturing, employing a 'molecule to market' approach. Argenta partners with companies worldwide to develop and bring animal health pharmaceuticals and products to market. Their expertise includes regulatory guidance, clinical studies, and manufacturing support, delivering over a billion doses of animal health medicines annually. With a large team of scientists, veterinarians, and consultants and multiple EMA and FDA-approved manufacturing locations, Argenta is dedicated to advancing animal health through innovation, including the development of novel therapies like monoclonal antibodies and stem cells.